FedEx reaches 30 IATA CEIV Pharma certifications globally

FedEx Corp has secured its 30th IATA CEIV Pharma certification, extending the accreditation across its global air hubs and cargo handling facilities and placing the company among the transportation providers with one of the industry's largest networks recognised for pharmaceutical handling standards, the company announced on 28 August.

The CEIV Pharma certification, awarded by the International Air Transport Association, assesses whether an operator's facilities and processes meet defined standards for handling time-sensitive, temperature-controlled pharmaceutical shipments. FedEx said the milestone reflects the capabilities built out by FedEx Life Sciences, its dedicated healthcare logistics organisation, in moving critical, temperature-sensitive shipments for the healthcare industry.

IATA's global head of cargo, Brendan Sullivan, said the pharmaceutical industry depended on air transport to ensure time-sensitive and temperature-controlled medicines and therapies reached doctors and patients, and said IATA was pleased to see FedEx earn the industry's recognised mark of quality in pharmaceutical handling while continuing to expand its global network.

Nick Gennari, president of FedEx Healthcare and Life Sciences, said the company was proud to reach the milestone but that its work in the space was not finished, describing it as another step toward building one of the world's most advanced healthcare logistics networks, with quality remaining central to FedEx Life Sciences' ongoing expansion and its continued work with IATA.

FedEx Corp reported annual revenue of 86 billion US dollars and employs more than 450,000 people worldwide, offering a broad portfolio of transportation, e-commerce and business services built on an integrated global network.